First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors Meeting Abstract


Authors: Sanborn, R. E.; Patel, M. R.; Rodon, J.; Thein, K. Z.; Friedman, C.; Levitz, D.; Ngirailemesang, I.; Goodman, A.; Agarwal, P.; Friedman, E.; Danaee, H.; Robell, K.; Jaeger, S.; Sun, H.; Debanne, E.; Dunn, J.; Wright, E.; Reilly, T.; Luke, J. J.; Redig, A.
Abstract Title: First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sep 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S675
End Page: S676
Language: English
ACCESSION: WOS:001326612901296
DOI: 10.1016/j.annonc.2024.08.1050
PROVIDER: wos
Notes: Meeting Abstract: 991O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Claire Frances Friedman
    117 Friedman